Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Al Razi Medical CoSAU:9572 +1.88%39 PS Ratio is 0.54 as of Aug. 31, 2026, which is 53% below its 10-year median of 1.14. GuruFocus rates SAU:9572 with a GF Score™ of 39/100 and a GF Value™ of ﷼57.18 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Al Razi Medical Co ranks better than 77.71% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Al Razi Medical Co's share price is ﷼27.10.
Al Razi Medical Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼50.26. Hence, Al Razi Medical Co's PS Ratio for today is 0.54.
Good Sign:
Al Razi Medical Co stock PS Ratio (=0.54) is close to 5-year low of 0.54.
The historical rank and industry rank for Al Razi Medical Co's PS Ratio or its related term are showing as below:
SAU:9572'
s PS Ratio Range Over the Past 10 Years
Min: 0.53 Med: 1.14 Max: 2.23
Current: 0.54
During the past 4 years, Al Razi Medical Co's highest PS Ratio was 2.23. The lowest was 0.53. And the median was 1.14.
SAU:9572's PS Ratio is ranked better than 77.71% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 1.53
vs SAU:9572: 0.54
During the past 4 years, Al Razi Medical Co's highest 3-Year average Revenue per Share Growth Rate was 12.40% per year. The lowest was 12.40% per year. And the median was 12.40% per year.
Al Razi Medical Co (SAU:9572) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Al Razi Medical Co PS Ratio Related Terms
Al Razi Medical Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Al Razi Medical Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Al Razi Medical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Al Razi Medical Co PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Al Razi Medical Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Al Razi Medical Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Al Razi Medical Co's Share Price of today is ﷼27.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Al Razi Medical Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼50.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Al Razi Medical Co (SAU:9572) has a PS Ratio of 0.54 as of Aug. 31, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Al Razi Medical Co and its competitors. This is 53% below median its historical median of 1.14. Over the past decade, Al Razi Medical Co's PS Ratio has ranged from 0.53 to 2.23. According to the industry distribution chart, Al Razi Medical Co ranks #148 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 22.3%.
Is Al Razi Medical Co's PS Ratio too high?
Al Razi Medical Co's current PS Ratio of 0.54 is 53% below median its 10-year median of 1.14. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 2.23. The Healthcare Providers & Services industry median PS Ratio is 1.53. Al Razi Medical Co's value of 0.54 is 64.7% below this industry median. Based on the distribution chart, Al Razi Medical Co ranks #148 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Al Razi Medical Co has a GF Score™ of 39/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al Razi Medical Co's PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Al Razi Medical Co ranks #148 out of 664 companies for PS Ratio. This places Al Razi Medical Co in the top 22% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.53. Al Razi Medical Co's value of 0.54 is 64.7% below this benchmark. Historically, Al Razi Medical Co's own PS Ratio has ranged from 0.53 to 2.23 over the past decade. While the company's 10-year median is 1.14 vs. the industry median of 1.53, Al Razi Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.53, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Al Razi Medical Co's current PS Ratio of 0.54 is 64.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Al Razi Medical Co and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Al Razi Medical Co's current PS Ratio is 0.54, which is 53% below median its own 10-year median of 1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al Razi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Al Razi Medical Co (SAU:9572) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼57.18, compared to a current price of ﷼27.10 — trading 52.6% below its estimated fair value. The current PS Ratio is 0.54, which is 53% below median its 10-year median of 1.14 and 64.7% below the Healthcare Providers & Services industry median of 1.53. Al Razi Medical Co's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Al Razi Medical Co (SAU:9572), the current PS Ratio is 0.54 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Al Razi Medical Co (SAU:9572) Overvalued in 2026?
Based on GuruFocus' analysis, Al Razi Medical Co stock appears to be undervalued.
The current stock price of ﷼27.10 is trading 52.6% below its estimated GF Value™ of ﷼57.18.
GuruFocus considers Al Razi Medical Co to be Significantly Undervalued.
Key valuation signals for SAU:9572:
PS Ratio: 0.54 (53% below median its 10-year median of 1.14)
GF Value™: ﷼57.18 vs. price of ﷼27.10 (52.6% below fair value)
Industry Position: 64.7% below the Healthcare Providers & Services median (#148 of 664)
No single metric tells the full story. See the SAU:9572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Al Razi Medical Co operates in the medical field in the Kingdom of Saudi Arabia. The company provides all pharmaceutical and cosmetic products. It engages in buying and selling pharmaceuticals, medical supplies, herbal and cosmetic products, and all related products on a wholesale and retail basis.
39GF Score
Get the complete analysis for SAU:9572
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9572 has been successfully added to your 
